MooreKuehn.jpg
Moore Kuehn, PLLC Encourages Investors of OKTA and SPRO to Contact Law Firm
08 juin 2022 22h21 HE | Moore Kuehn
NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a securities law firm located on Wall Street, is investigating potential claims involving directors and officers regarding possible...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Okta, Enservco, CareDx, and Spero and Encourages Investors to Contact the Firm
08 juin 2022 21h00 HE | Bragar Eagel & Squire
NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Twitter, LMP, and Spero and Encourages Investors to Contact the Firm
03 juin 2022 21h00 HE | Bragar Eagel & Squire
NEW YORK, June 03, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
Spero Class Action Complaint Filed: Johnson Fistel, Globally Recognized Law Firm, Encourages Shareholders to Submit Their Losses
26 mai 2022 17h21 HE | Johnson Fistel, LLP
SAN DIEGO, May 26, 2022 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of Spero Therapeutics, Inc....
Spero Sunflower Cream Cheese
Could Sunflowers Solve the Cream Cheese Crisis? Spero® Says Yes. Expanding Into Food Service.
16 déc. 2021 09h00 HE | Spero Foods
NEW YORK, Dec. 16, 2021 (GLOBE NEWSWIRE) -- Don't panic bagel connoisseurs and professional shmear-ers, Spero® Sunflower® Cream Cheese has it covered and is here to solve the cream cheese crisis as...
Spero.jpg
Spero Therapeutics Announces Proposed Rights Offering
30 janv. 2020 08h00 HE | Spero Therapeutics, Inc.
CAMBRIDGE, Mass., Jan. 30, 2020 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and...